1-6 of 6
Debra Wolff, MS, PCNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, Debra Wolff, MS, PCNP, Nicole M. Kuderer, MD, David C. Dale, MD
Journal: Blood
Blood (2009) 114 (22): 3100.
https://doi.org/10.1182/blood.V114.22.3100.3100
Published: 2009
Journal Articles

Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Nicole M. Kuderer, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, David C. Dale, MD
Journal: Blood
Blood (2008) 112 (11): 1312.
https://doi.org/10.1182/blood.V112.11.1312.1312
Published: 2008
Journal Articles

Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Gary H. Lyman, MD, MPH, David C. Dale, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, MS, Nicole M. Kuderer, MD, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD
Journal: Blood
Blood (2008) 112 (11): 2390.
https://doi.org/10.1182/blood.V112.11.2390.2390
Published: 2008
Journal Articles

A Prospective Risk Model for Neutropenic Complications in Patients with Malignant Lymphoma.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD
Journal: Blood
Blood (2005) 106 (11): 3328.
https://doi.org/10.1182/blood.V106.11.3328.3328
Published: 2005
Journal Articles

Dose Intensity and Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy.

Michelle Shayne, MD, Eva Culakova, Ph.D, Marek S. Poniewierski, MD, MS, Debra Wolff, MS, PCNP, David C. Dale, MD, Jeffrey Crawford, MD, Gary H. Lyman, MD, MPH
Journal: Blood
Blood (2005) 106 (11): 3124.
https://doi.org/10.1182/blood.V106.11.3124.3124
Published: 2005
Journal Articles

A Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Gary H. Lyman, MD, MPH, Brandon McMahon, MD, Nicole M. Kuderer, MD, Jeffrey Crawford, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD
Journal: Blood
Blood (2005) 106 (11): 754.
https://doi.org/10.1182/blood.V106.11.754.754
Published: 2005